Citations for: Stanczyk, F. Z.; Archer, D. F., Gestodene: a review of its pharmacology, potency and tolerability in combined contraceptive preparations. Contraception 2014, 89 (4), 242-52.

Entry Type
Name
Value
Parent Entry
Toxicology Data Field
Headaches, breast tension, acne, nervousness, depression, dizziness
Gestodene (API)
Pharmacology Data Field
Reported as agonist with high relative binding affinity and no antagonist activity, but Stanczyk notes that data consistent with low androgenic potential and strong antagonist effects demonstrated in vitro.
Gestodene (API)
Pharmacology Data Field
Binds. Activity reports vary slightly: reported as an antagonist (Ruan, Lello, Kuhl), while Africander reports that some antagonist activity is seen in rat models and Stanczyk claims it to be relatively weak compared to progesterone.
Gestodene (API)
Toxicology Data Field
Oral contraceptives containing gestodene are considered a safe, effective, well-tolerated option.
Gestodene (API)